Our team

Team

Mr. Fernando Barrera

Co-founder and CEO

Degree in Physical Sciences. Ignite start-ups acceleration course 2013, at the Cambridge Judge School. EU in Business Management by the UIB and Project Management by the UPC. Executive Master in Innovation by the EOI. Fourteen years of experience in technology transfer activities and R&D project management as Head of the Technology Transfer Unit of the University of the Balearic Islands (UIB OTRI). He has managed and directed more than twenty national and international R&D projects. Vice-president of the biotechnology and biomedicine cluster of the Balearic Islands.

Dr. Rafel Prohens

Co-founder and Scientific Advisor

PhD in Organic Chemistry by the University of the Balearic Islands. He was a Postdoctoral Research Associate (2001-2002) and a Visiting Researcher (2009, 2013-2015) at the University of Sheffield (UK). He is the Manager of the Polymorphism and Calorimetry Unit of the University of Barcelona since 2004. He has directed more than 80 R&D projects about Polymorphism and Cocrystals for the pharmaceutical industry, and supervised 4 PhD Thesis and 4 MSc Thesis in the fields of Crystal Engineering and Supramolecular Chemistry. He has published 70 research papers in scientific journals, filed 10 international patents and given 25 invited conferences in International Congresses and Seminars.

Mr. Ignasi Miquel

COO

Bachelor’s in Chemistry. MBA. Additional formation on Business Development (by BIO-Licensing Executives Society, in Boston) and for executives in Biotechnology. 24 years of experience in the biopharmaceutical industry first 10 in Research and Development, in different positions in Laboratorios SALVAT, LACER, J.Isern Patentes y Marcas, and in Thrombotargets. 14 years of experience in management, as Strategic Alliances and Business Development Director, in Thrombotargets. He has managed and directed more than 15 national R&D projects. He is the co-author of 8 scientific publications, 6 communications in international congresses, and co-inventor of 6 international patents.

Mr. David Roldán

CFO

Bachelor’s in economics, and Master in Banking and Finance. Managing partner of the consulting firm Timonel Consulting, a financial consultancy based in Palma de Mallorca. He has 15 years of experience in strategic consulting, business risk analysis, account auditing, and financial consulting. Full professor at the Escola Superior de Balears (ESB) and Palma Activa

Dr. Joan Albertí

CSO

Doctor in Analytical Chemistry. Adjunct Professor in Masters in Pharmaceutical Industry at the University of Barcelona, and at the Pompeu Fabra University. More than 15 years of research experience in the pharmaceutical industry, in the field of drug metabolism and pharmacokinetics, at Almirall, the leading Spanish pharmaceutical company. He is the author of 21 publications and 20 presentations at international conferences.

Board of Directors

Dr. Joan Perelló

Chairman of the Board

PhD in Chemistry by the University of the Balearic Islands (UIB). Founder and CEO of Sanifit, a biopharmaceutical company. President of the BIOIB cluster, Vice Chancellor of the Official College of Chemistry of the Balearic Islands, and Associate Professor at the University of the Balearic Islands since 2006. He has managed to raise more than 100M Eur of private capital for the development of Sanifit products, and two license agreements in the health and medical consumer technology sectors. Co-author in over 50 peer-reviewed international publications, , co-inventor of 10 international patents. He has participated in 30 research projects being PI in half of them.

Mr. Fernando Barrera

Board Member

Degree in Physical Sciences. Ignite start-ups acceleration course 2013, at the Cambridge Judge School. EU in Business Management by the UIB and Project Management by the UPC. Executive Master in Innovation by the EOI. Fourteen years of experience in technology transfer activities and R&D project management as Head of the Technology Transfer Unit of the University of the Balearic Islands (UIB OTRI). He has managed and directed more than twenty national and international R&D projects. He is Vice-president of the biotechnology and biomedicine cluster of the Balearic Islands.

Dr. Mireia Angulo

Board Member

Doctor in Biology by the University of Barcelona and MBA from EADA. She is an investment manager at Caixa Capital Risc, the Venture Capital division of La Caixa. It focuses on the life sciences sector, leading investments in companies that develop therapeutic, diagnostic and medical devices. She is currently a counselor at ProteoDesign, Inbiomotion or Numat Medtech, as well as at CIRCE. Before Caixa Capital Risc, Mireia was an investment analyst at Healthequity, a venture capital fund focused on the healthcare sector. She previously worked in the Technology Transfer Unit offices of the University of Barcelona and the Hospital Clínico de Barcelona.

Mr. José Antonio de Paz

Board Member

M.D. of Medicine from the University of Salamanca, Scholarship in Anesthesiology and Pain Medicine at the University Hospital of La Paz, in Madrid. Head of Anesthesiology at Clínica Rotger. Master in Innovation Management at OBS Business School. His career as an entrepreneur has led him to be CEO at Paz Cruz S.L, at Biotech 2013, and CSO at MEL Pharma.